Porphyria cutanea tarda: An analysis of HFE gene mutations, hepatitis viruses, alcohol intake, and other risk factors in 54 patients from Guipúzcoa, Basque Country, Spain;Porfiria cutánea tarda: Asociación con mutaciones HFE, hepatitis virales, alcohol y otros factores de riesgo en Guipúzcoa, País Vasco

Revista Espanola de Enfermedades Digestivas

Volumn 100, Issue 12, 2008, Pages 774-778

  Castiella, Agustín ^a   Zapata, E ^a   De Juan, M D ^b   Mugica F ^b   Barrio, J ^c   Otazua, P ^d   Arriola, J A ^b   Cosme, A ^b   Elosegui, E ^b   Fernandez J ^a   Zubiaurre, L ^a   Alzate, L F ^b   Utrilla, E ^e  

^a HOSPITAL DE MENDARO   (Spain)

^b HOSPITAL DONOSTIA   (Spain)

^c Hospital Bidasoa   (Spain)

^d Hospital Mondragón   (Spain)

^e Centro de Salud Zarauz   (Spain)

Author keywords

HFE gene; Liver diseases; Porphyria cutanea tarda

Indexed keywords

ALCOHOL; ESTROGEN; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN;

ADULT; AGED; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ARTICLE; BLOOD DONOR; CHI SQUARE TEST; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HETEROZYGOSITY; HFE GENE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; POPULATION; PORPHYRIA CUTANEA TARDA; PREVALENCE; PROBABILITY; RISK FACTOR; SPAIN; ALCOHOLISM; GENETICS; MIDDLE AGED; MUTATION; RETROSPECTIVE STUDY; VIRUS HEPATITIS;

ADULT; AGED; ALCOHOLISM; FEMALE; HEPATITIS, VIRAL, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PORPHYRIA CUTANEA TARDA; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; YOUNG ADULT;

EID: 64749109570     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Alla V, Bonkovsky HL. Iron in nonhemochromatotic liver disorders. Semin Liver Dis 2005; 25: 461-472 (Pubitemid 41741262)
2. Sebastiani G, Walker AP. HFE gene in primary and secondary hepatic iron overload. World J Gastroenterol 2007; 13: 4673-4689 (Pubitemid 47455558)
3. Gisbert JP, García-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis. J Hepatol 2003; 39: 620-627 (Pubitemid 37204664)
4. Martinelli ALC, Zago MA, Roselino AMF, Filho AB, Villanova MG, Secaf M, et al. Porphyria cutanea tarda in brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection. Am J Gastroenterol 2000; 95: 3516-3521
5. Elder GH, Urquhart AJ, De Salamanca RE, Muñoz JJ, Bonkovsky HL. Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda. Lancet 1985; 2: 229-233
6. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408. (Pubitemid 26256612)
7. De Juan MD, Reta A, Castiella A, Pozueta J, Prada A, CuadradoE. HFE gene mutations analysis in Basque hereditary haemochromatosis patients and controls. Eur J Hum Genet 2001; 9: 961-964
8. Castiella A, Zapata E, Otazua P, Fernandez J, Alustiza JM, Ugarte M, et al. Utilidad de los diferentes métodos no invasivos de predicción de fibrosis hepática en pacientes del País Vasco con hemocromatosis fenotípica. Rev Esp Enferm Dig 2008 (en prensa).
9. Garcia-Bengoechea M, Emparanza JI, Sarriugarte A, Cortés A, Vega JL, González F, et al. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery. Eur J Gastroenterol Hepatol 1995; 7: 237-241 (Pubitemid 19187041)
10. Herrero C, Vicente A, Bruguera M, Ercilla MG, Barrera JM, Vidal J, et al. Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 1993; 341: 788-789
11. Lacour JP, Bodokh I, Castanet J, Bekri S, Ortonne JP. Porphyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol 1993; 128: 121-123 (Pubitemid 23054327)
12. Fargion S, Piperno A, Cappellini MD, Sampietro M, Fracanzani AL, Romano R, et al. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology 1992; 16: 1322-1326
13. Murphy A, Dooley S, Hillary IB, Murphy GM. HCV infection in porphyria cutanea tarda. Lancet 1993; 341: 1534-1535 (Pubitemid 23168668)
14. Stolzel U, Kostler E, Koszka C, Stöffler-Meilecke M, Schuppan D, Somasundaram R, et al. Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. Hepatology 1995; 21: 1500-1503
15. Gibson PR, Ratnaike S, Blake D, Sinickas V. Porphyria cutanea tarda and hepatitis C (letter). Med J Aust 1995; 162: 54.
16. Stuart KA, Busfield F, Jazwinska EC, Gibson P, Butterworth LA, Cooksley WG, et al. The C282Y mutation in the hemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients. J Hepatol 1998; 28: 404-409 (Pubitemid 28133543)
17. Nagy Z, Koszo F, Par A, Emri G, Horkay I, Horanyi M, et al. Hemochromatosis (HFE) gene mutations and hepatitis C virus infection as risk factors for porphyria cutanea tarda in Hunagarian patients. Liver Int 2004; 24: 16-20. (Pubitemid 38351209)
18. Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, Obando J, Di Bisceglie, Tattrie C, et al. Porphyria cutanea tarda, hepatitis C and HFE gene mutations in North America. Hepatology 1998; 27: 1661-1669
19. Martín-Vivaldi Martínez R, Espinosa Aguilar MD, Sánchez Sánchez-Vizcaíno J, Quintero Fuentes D, Nogueras López F, López de Hierro Ruiz M. Association of porphyria cutanea tarda and hepatitis C virus. Rev Esp Enferm Dig 1996; 88: 213-216 (Pubitemid 126502075)
20. López Morante A, Saez Royuela F, Martín Lorente JL, Yuguero del Moral, Ojeda Giménez C. Hepatitis C virus infection and porphyria cutanea tarda. Gastroenterol Hepatol 1995; 18: 7-10.
21. Pérez-Trallero E, Cilla G, Saenz J, Montes M, Idigoras P. Low risk of mother to infant transmission of hepatitis B virus in Guipúzcoa (Basque country, northern Spain). Eur J Epidemiol 1992; 8: 878-881 (Pubitemid 23018365)
22. Schiff E. Hepatitis C and alcohol. Hepatology 1997; 26: 39-42. (Pubitemid 27388070)
23. Fargion S, Fracanzani AL, Romano R, Cappellini MD, Faré M, Mattioli M, et al. Genetic hemochromatosis in Italian patients with porphyria cutanea tarda: possible explanation for iron overload. J Hepatol 1996; 24: 564-569
24. Sinclair PR, Gorman N, Trask HW, Bement WJ, Szakacs JG, Elder GH, et al. Uroporphyria caused by ethanol in Hfe(-/-) mice as a model for porphyria cutanea tarda. Hepatology 2003; 37: 351-358
25. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997; 349: 321-323 (Pubitemid 27056825)
26. Bulaj ZJ, Phillips JD, Ajioka RS, Franklin M, Griffen LM, Guinee DJ, et al. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood 2000; 95: 1565-1571
27. Egger NG, Goeger DE, Payne DA, Miskovsky EP, Weinman SA, Anderson KE. Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency. Dig Dis Sci 2002; 47: 419-426 (Pubitemid 34124005)
28. Tannapfel A, Stolzel U, Kostler E, Melz S, Richter M, Keim V, et al. C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients. Virchows Arch 2001; 439: 1-5.
29. Sampietro M, Piperno A, Lupica L, Arosio C, Vergani A, Corbetta N, et al. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology 1998; 27: 181-184
30. Dereure O, Aguilar-Martinez P, Bessis D, Perney P, Vallat C, Guillot B, et al. HFE mutations and transferring receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France. Br J Dermatol 2001; 144: 533-539
31. Stolzel U, Kostler E, Schuppan D, Richter M, Wollina U, Doss MO, et al. Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda. Arch Dermatol 2003; 139: 309-313
32. González-Hevilla M, De Salamanca RE, Morales P, Martínez-Laso J, Fontanellas A, Castro MJ, et al. Human leukocyte antigen haplotypes and HFE mutations in Spanish hereditary hemochromatosis and sporadic porphyria cutanea tarda. J Gastroenterol Hepatol 2005; 20: 456-462
33. Toll A, Celis R, Ozalla MD, Bruguera M, Herrero C, Ercilla MG. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection. J Eur Acad Dermatol Venereol 2006; 20: 1201-1206 (Pubitemid 44614615)
34. Cruz-Rojo J, Fontanellas A, Morán-Jiménez MJ, Navarro-Ordóñez S, García-Bravo M, Méndez M, et al. Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients. Cell Mol Biol (Noisy-le-grand) 2002; 48: 845-852
35. Bauduer F, Scribans C, Degioanni A, Renoux M, Dutour O. Distribution of the C282Y and H63D polymorphisms in hereditary hemochromatosis patients from the French Basque Country. Ann Hematol 2005; 84: 99-102. (Pubitemid 40089764)